Zobrazeno 1 - 5
of 5
pro vyhledávání: '"André, Lhoir"'
Autor:
Thomas, Morel, André, Lhoir, Eline, Picavet, Segundo, Mariz, Bruno, Sepodes, Jordi, Llinares, David, Cassiman
Publikováno v:
Nature reviews. Drug discovery. 15(6)
Autor:
Bruno Sepodes, Thomas Morel, André Lhoir, Jordi Llinares, Segundo Mariz, Eline Picavet, David Cassiman
Publikováno v:
Nature Reviews Drug Discovery. 15:376-376
Autor:
Kerstin, Westermark, Birthe Byskov, Holm, Mirjam, Söderholm, Jordi, Llinares-Garcia, Frida, Rivière, Stiina, Aarum, Florence, Butlen-Ducuing, Stelios, Tsigkos, Agnieszka, Wilk-Kachlicka, Cinzia, N'Diamoi, János, Borvendég, David, Lyons, Bruno, Sepodes, Brigitte, Bloechl-Daum, André, Lhoir, Mariana, Todorova, Ioannis, Kkolos, Kateřina, Kubáčková, Heidrun, Bosch-Traberg, Vallo, Tillmann, Veijo, Saano, Emmanuel, Héron, Rembert, Elbers, Miranda, Siouti, Judit, Eggenhofer, Patrick, Salmon, Maurizio, Clementi, Dainis, Krieviņš, Aušra, Matulevičiene, Henri, Metz, Albert Cilia, Vincenti, Albertha, Voordouw, Bożenna, Dembowska-Bagińska, Ana Corrêa, Nunes, Flavia Mirela, Saleh, Tatiana, Foltánová, Martin, Možina, Josep, Torrent i Farnell, Björn, Beerman, Segundo, Mariz, Marie Pauline, Evers, Lesley, Greene, Sigurdur, Thorsteinsson, Lars, Gramstad, Maria, Mavris, Fabrizia, Bignami, Annie, Lorence, Chantal, Belorgey
Publikováno v:
Nature reviews. Drug discovery. 10(5)
In 2000, regulation on orphan medicinal products was adopted in the European Union with the aim of benefiting patients who suffer from serious, rare conditions for which there is currently no satisfactory treatment. Since then, more than 850 orphan d
Autor:
Tatiana Foltanova, Albertha Voordouw, Laura Fregonese, Bruno Sepodes, André Lhoir, Segundo Mariz, Daniel O’Connor, Jordi Llinares, Stelios Tsigkos, Pauline J Evers, Bożenna Dembowska-Bagińska, Ana Corrêa-Nunes, Kerstin Westermark, Rembert Elbers, Stiina Aarum
Publikováno v:
Orphanet Journal of Rare Diseases
The use of biomarkers within the procedures of the Committee of Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) is discussed herein. The applications for Orphan Medicinal Product designation in the EU are evaluated at two stag
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.